Maintain the Current Atenolol 100 mg Dose
In a 76-year-old patient with a resting heart rate of 57 bpm on atenolol 100 mg daily, the dose should be maintained unless the patient is symptomatic. A heart rate of 57 bpm is not considered problematic in the absence of symptoms such as dizziness, lightheadedness, or evidence of hypoperfusion.
Rationale Based on Guidelines
Asymptomatic Bradycardia Does Not Require Intervention
Multiple heart failure guidelines consistently state that bradycardia induced by beta-blockers is generally asymptomatic and requires no treatment 1, 2, 3. The 2012 ESC Heart Failure Guidelines specifically note that if heart rate falls below 50 bpm with worsening symptoms, only then should the beta-blocker dose be halved 1. The 2009 ACC/AHA guidelines similarly state that "the slowing of heart rate and cardiac conduction produced by beta blockers is generally asymptomatic and thus generally requires no treatment" 3.
When to Consider Dose Reduction
You should only reduce the atenolol dose if:
- Symptomatic bradycardia occurs (dizziness, lightheadedness, confusion) 1, 2, 3
- Heart rate drops below 50 bpm AND symptoms worsen 1
- Second- or third-degree heart block develops 2, 3
- Evidence of peripheral hypoperfusion is present 3
Age-Specific Considerations for Atenolol
The FDA labeling for atenolol provides specific guidance for elderly patients 4. Atenolol is renally excreted, and dose adjustment should be considered in elderly patients with renal impairment. The key question is whether this patient has adequate renal function:
- If creatinine clearance is >35 mL/min/1.73m²: The current 100 mg daily dose is appropriate 4
- If creatinine clearance is 15-35 mL/min/1.73m²: Maximum dose should be 50 mg daily 4
- If creatinine clearance is <15 mL/min/1.73m²: Maximum dose should be 25 mg daily 4
Clinical Algorithm
Step 1: Assess for symptoms
- Ask about dizziness, lightheadedness, confusion, or fatigue
- Check blood pressure for symptomatic hypotension
- If symptomatic → reduce dose by 50%
- If asymptomatic → proceed to Step 2
Step 2: Check renal function
- Obtain creatinine clearance
- If CrCl >35 mL/min → maintain 100 mg daily
- If CrCl 15-35 mL/min → reduce to 50 mg daily
- If CrCl <15 mL/min → reduce to 25 mg daily
Step 3: Review concomitant medications
- Identify other heart rate-lowering drugs (digoxin, amiodarone, diltiazem, verapamil) 1
- Consider discontinuing or reducing these before adjusting beta-blocker 1
Step 4: Obtain ECG
- Rule out second- or third-degree AV block 2, 3
- If heart block present → reduce or discontinue beta-blocker
Important Caveats
Atenolol-Specific Limitations
The 2016 ESC Atrial Fibrillation Guidelines note that atenolol is not recommended as specific rate control therapy due to its short biological half-life 5. However, this recommendation applies primarily to atrial fibrillation rate control, not to other indications like hypertension or post-MI therapy where the patient may already be established on treatment.
Do Not Abruptly Discontinue
Never stop beta-blockers suddenly unless absolutely necessary 1, 2. There is risk of rebound myocardial ischemia, infarction, and arrhythmias 1, 2. If dose reduction is needed, taper gradually and monitor closely.
Target Heart Rate Context Matters
The appropriate target heart rate depends on the indication:
- Heart failure: Initial target <110 bpm, with careful avoidance of excessive bradycardia 1
- Acute coronary syndrome: Target 50-60 bpm may be appropriate 6
- Hypertension/stable angina: Heart rate of 57 bpm is acceptable if asymptomatic
Bottom Line
Maintain the atenolol 100 mg daily dose if the patient is asymptomatic and has adequate renal function (CrCl >35 mL/min). A resting heart rate of 57 bpm represents appropriate beta-blockade in an elderly patient and does not warrant dose reduction in the absence of symptoms or significant renal impairment. Check renal function and assess for symptoms before making any changes.